BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 37008128)

  • 1. Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance.
    Dhanda G; Acharya Y; Haldar J
    ACS Omega; 2023 Mar; 8(12):10757-10783. PubMed ID: 37008128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens.
    Kumar V; Yasmeen N; Pandey A; Ahmad Chaudhary A; Alawam AS; Ahmad Rudayni H; Islam A; Lakhawat SS; Sharma PK; Shahid M
    Front Cell Infect Microbiol; 2023; 13():1293633. PubMed ID: 38179424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
    Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
    Elife; 2022 Jan; 11():. PubMed ID: 35025730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic Adjuvants: Make Antibiotics Great Again!
    Douafer H; Andrieu V; Phanstiel O; Brunel JM
    J Med Chem; 2019 Oct; 62(19):8665-8681. PubMed ID: 31063379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic adjuvants - A strategy to unlock bacterial resistance to antibiotics.
    González-Bello C
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4221-4228. PubMed ID: 28827113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Basis of Combination Therapy to Combat Antibiotic Resistance.
    Si Z; Pethe K; Chan-Park MB
    JACS Au; 2023 Feb; 3(2):276-292. PubMed ID: 36873689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Adjuvants: A Promising Approach to Combat Multidrug Resistant Bacteria.
    Sharma N; Chhillar AK; Dahiya S; Choudhary P; Punia A; Gulia P
    Curr Drug Targets; 2021; 22(12):1334-1345. PubMed ID: 33494671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance.
    Chawla M; Verma J; Gupta R; Das B
    Front Microbiol; 2022; 13():887251. PubMed ID: 35847117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition.
    Dashtbani-Roozbehani A; Brown MH
    Antibiotics (Basel); 2021 Dec; 10(12):. PubMed ID: 34943714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance breakers: current approaches and future directions.
    Laws M; Shaaban A; Rahman KM
    FEMS Microbiol Rev; 2019 Sep; 43(5):490-516. PubMed ID: 31150547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring and Enhancing the Potency of Existing Antibiotics against Drug-Resistant Gram-Negative Bacteria through the Development of Potent Small-Molecule Adjuvants.
    Yu B; Roy Choudhury M; Yang X; Benoit SL; Womack E; Van Mouwerik Lyles K; Acharya A; Kumar A; Yang C; Pavlova A; Zhu M; Yuan Z; Gumbart JC; Boykin DW; Maier RJ; Eichenbaum Z; Wang B
    ACS Infect Dis; 2022 Aug; 8(8):1491-1508. PubMed ID: 35801980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance.
    Wright GD
    Trends Microbiol; 2016 Nov; 24(11):862-871. PubMed ID: 27430191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance].
    Aygül A
    Mikrobiyol Bul; 2015 Apr; 49(2):278-91. PubMed ID: 26167829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
    Liu Y; Li R; Xiao X; Wang Z
    Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of a Potent Multidrug Efflux Pump Variant That Enhances Campylobacter Resistance to Multiple Antibiotics.
    Yao H; Shen Z; Wang Y; Deng F; Liu D; Naren G; Dai L; Su CC; Wang B; Wang S; Wu C; Yu EW; Zhang Q; Shen J
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Mechanisms of Antibiotic Resistance and the Role of Antibiotic Adjuvants.
    Pontes DS; de Araujo RSA; Dantas N; Scotti L; Scotti MT; de Moura RO; Mendonca-Junior FJB
    Curr Top Med Chem; 2018; 18(1):42-74. PubMed ID: 29412107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-Molecular Adjuvants with Weak Membrane Perturbation Potentiate Antibiotics against Gram-Negative Superbugs.
    Dhanda G; Mukherjee R; Basak D; Haldar J
    ACS Infect Dis; 2022 May; 8(5):1086-1097. PubMed ID: 35404568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Antibiotic Adjuvant Ratios Can Slow and Steer the Evolution of Resistance: Co-amoxiclav as a Case Study.
    Allen RC; Brown SP
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.
    Shin B; Park W
    J Microbiol; 2017 Nov; 55(11):837-849. PubMed ID: 29076065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.